Sun et al. [92] uncovered that LNC942 recruits methyltransferase-like 14 (METTL14) as an oncogene and increases the downstream target genes CXCR4 and CYP1B1 expression and stability by promoting post-transcriptional m6A methylation, thereby promoting BC cell proliferation and malignant progression. The gene discussed is METTL14; the disease is breast cancer.